Thyroid Cancer clinical trials in Connecticut

4 actively recruiting thyroid cancer trials at 15 sites across Connecticut.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

This phase III trial compares the effect of cabozantinib versus combination dabrafenib and trametinib for the treatment of patients with differentiated thyroid cancer that does not respond to treatment (refractory) and which expresses a BR…

Sponsor: ECOG-ACRIN Cancer Research Group

NCT ID: NCT06475989

Sites in Connecticut:

Smilow Cancer Hospital-Derby Care Center — Derby, Connecticut
Smilow Cancer Hospital Care Center-Fairfield — Fairfield, Connecticut
Smilow Cancer Hospital Care Center at Glastonbury — Glastonbury, Connecticut
Smilow Cancer Hospital Care Center at Greenwich — Greenwich, Connecticut
Smilow Cancer Hospital Care Center - Guilford — Guilford, Connecticut

View on ClinicalTrials.gov →

Phase 1, Phase 2 Recruiting Industry

A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

This is a study to evaluate the safety and potential anti-tumor activity of an investigational agent called ARV-806 in Adults with Advanced Cancer having a specific KRAS mutation. This is an open-label study which means that participants a…

Sponsor: Arvinas Inc.

NCT ID: NCT07023731

Sites in Connecticut:

Clinical Trial Site — New Haven, Connecticut

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in Connecticut:

Veterans Affairs Connecticut Healthcare System-West Haven Campus — West Haven, Connecticut

View on ClinicalTrials.gov →

Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska

NCT ID: NCT02012699

Sites in Connecticut:

Prospect Medical Hospital — Manchester, Connecticut

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20